UBS Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.63M | Sell |
|
|||||
|
2025
Q2 | $15.1M | Buy |
|
|||||
|
2025
Q1 | $7.44M | Sell |
|
|||||
|
2024
Q4 | $10.7M | Buy |
|
|||||
|
2024
Q3 | $1.59M | Buy |
|
|||||
|
2024
Q2 | $552K | Sell |
|
|||||
|
2024
Q1 | $1.07M | Buy |
|
|||||
|
2023
Q4 | $9.47K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $18.9K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $0 | Sell |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $525K | Buy |
|
|||||
|
2021
Q3 | $137K | Buy |
|
|||||
|
2021
Q2 | $5K | Sell |
|
|||||
|
2021
Q1 | $154K | Buy |
|
|||||
|
2020
Q4 | $4K | Buy |
|